Achilles Corporation (JP:5142)
:5142
Want to see JP:5142 full AI Analyst Report?
Top Page
Achilles Corporation
(5142)
Select Model
Select Model
Rating:56Neutral
Price Target:
¥1,306.00
▼(-9.68% Downside)
Action:Reiterated
Date:05/13/26
The score is held back primarily by weak cash flow quality (persistently negative free cash flow) and a technically weak setup (below key moving averages, negative MACD). These are partly offset by improved 2026 profitability and a reasonable balance sheet, plus an attractive valuation (low P/E and moderate dividend yield).
Positive Factors
Diversified Polymer Product Base
Achilles sells polymer and resin products into footwear, industrial, construction and consumer markets. This product and end-market diversification reduces reliance on any single cycle, supporting more stable revenue streams and demand exposure over the next several months.
Negative Factors
Persistent Negative Free Cash Flow
Repeated negative free cash flow, even in a profitable year, signals cash conversion issues and ongoing cash burn after investments. This undermines self-funded growth, raises refinancing or external funding risk, and constrains dividends or debt reduction over coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Polymer Product Base
Achilles sells polymer and resin products into footwear, industrial, construction and consumer markets. This product and end-market diversification reduces reliance on any single cycle, supporting more stable revenue streams and demand exposure over the next several months.
Read all positive factors
Achilles Corporation (5142) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥17.53B
Dividend Yield1.39%
Average Volume (3M)60.26K
Price to Earnings (P/E)7.9
Beta (1Y)1.06
Revenue Growth3.43%
EPS Growth490.61%
CountryJP
Employees1,689
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)48.47
Shares Outstanding14,562,714
10 Day Avg. Volume46,570
30 Day Avg. Volume60,263
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.42
Price to Sales (P/S)0.22
P/FCF Ratio-75.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Achilles Corporation Business Overview & Revenue Model
Company Description
Achilles Corporation manufactures and sells shoes, plastic products, and industrial materials in Japan. It offers walking and sports shoes for kids, women, and men under the Achilles SORBO, SYUNSOKU, SYUNSOKU Baby, SYUNSOKU Junior, SYUNSOKU DANCE,...
How the Company Makes Money
Achilles Corporation generates revenue primarily through the manufacture and sale of polymer-based products and materials to business and consumer markets. Key revenue streams include (1) sales of industrial and construction-related materials (e.g...
Achilles Corporation Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
66
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.69B | 81.80B | 79.09B | 78.61B | 82.92B | 75.95B |
| Gross Profit | 15.01B | 17.52B | 14.19B | 14.18B | 14.85B | 15.66B |
| EBITDA | 4.12B | 5.71B | 3.81B | -1.21B | 2.13B | 5.42B |
| Net Income | 712.00M | 2.12B | 427.00M | -8.21B | -1.20B | 1.52B |
Balance Sheet | ||||||
| Total Assets | 78.25B | 83.63B | 79.50B | 82.66B | 86.22B | 80.12B |
| Cash, Cash Equivalents and Short-Term Investments | 6.98B | 9.75B | 7.72B | 6.85B | 6.89B | 7.59B |
| Total Debt | 14.65B | 17.15B | 14.65B | 14.65B | 11.10B | 5.20B |
| Total Liabilities | 39.52B | 40.34B | 40.17B | 43.11B | 40.01B | 32.39B |
| Stockholders Equity | 38.73B | 43.28B | 39.34B | 39.55B | 46.21B | 47.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -238.00M | -1.11B | -2.37B | -5.91B | -1.41B |
| Operating Cash Flow | 0.00 | 2.64B | 2.69B | 1.88B | -1.07B | 4.71B |
| Investing Cash Flow | 0.00 | -2.86B | -1.92B | -3.79B | -4.48B | -5.03B |
| Financing Cash Flow | 0.00 | 2.15B | -1.25B | 1.76B | 4.55B | -860.00M |
Achilles Corporation Technical Analysis
Negative
1446.00
Price Trends
1376.90
Negative
1450.46
Negative
1329.29
Negative
Market Momentum
-60.85
Positive
39.06
Neutral
54.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5142, the sentiment is Negative. The current price of 1446 is above the 20-day moving average (MA) of 1306.80, above the 50-day MA of 1376.90, and above the 200-day MA of 1329.29, indicating a bearish trend. The MACD of -60.85 indicates Positive momentum. The RSI at 39.06 is Neutral, neither overbought nor oversold. The STOCH value of 54.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:5142.
Achilles Corporation Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.18B | 8.51 | ― | 3.53% | -7.83% | 13.79% | |
74 Outperform | ¥132.47B | 49.21 | ― | 0.67% | 8.51% | -17.90% | |
63 Neutral | ¥28.56B | 15.39 | ― | 3.45% | 4.08% | 8.34% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ¥17.53B | 7.86 | ― | 1.39% | 3.43% | 490.61% | |
56 Neutral | ¥7.77B | 24.58 | ― | 2.97% | 2.12% | -64.98% | |
55 Neutral | ¥21.58B | 32.05 | ― | 4.09% | -1.03% | -40.31% |
* Basic Materials Sector Average
JP:5142
Achilles Corporation
1,217.00
32.51
2.74%
JP:3553
Kyowa Leather Cloth Co., Ltd.
881.00
136.04
18.26%
JP:4531
Yuki Gosei Kogyo Co., Ltd.
356.00
96.57
37.22%
JP:4970
Toyo Gosei Co., Ltd.
16,690.00
12,177.99
269.90%
JP:5013
Yushiro Chemical Industry Co., Ltd.
3,320.00
1,393.57
72.34%
JP:7925
Maezawa Kasei Industries Co., Ltd.
1,926.00
99.49
5.45%
Achilles Corporation Corporate Events
Achilles Unveils FY2026 Results, FY2027 Outlook and Mid-Term Plan Progress
May 12, 2026
Achilles Corporation released supplementary materials outlining its financial results for the fiscal year ended March 31, 2026, and provided forecasts for the year ending March 31, 2027, alongside an update on the progress of its mid-term manageme...
Achilles lifts profit forecasts beat and doubles year-end dividend on stronger margins
May 12, 2026
Achilles Corporation reported full-year results for the period ended March 31, 2026, that surpassed its earlier forecasts on both a consolidated and non-consolidated basis, driven by a richer sales mix of high-margin medical and industrial films a...
Achilles rebounds to strong profit, doubles dividend but guides for weaker year ahead
May 12, 2026
Achilles Corporation reported a 3.4% increase in net sales to ¥81.8 billion for the fiscal year ended March 31, 2026, with operating profit rebounding to ¥2.97 billion from a loss and profit attributable to owners of the parent surging t...
Achilles Revamps Board and Executive Lineup to Bolster Governance and Overseas Focus
Mar 27, 2026
Achilles Corporation announced planned changes to its board and executive structure, including the appointment of industry veteran Haruko Kokue as a new external director, adding extensive experience in chemicals, CSR, and corporate communications...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.